National Stock Exchange of India finally did on Thursday what market watchers have been waiting for since roughly 2016, it listed. Nine years of co-location scam fallout, SEBI back-and-forth and postponed timelines ended with shares hitting the board at Rs. 1,800 apiece, a modest 0.84 percent pop over the Rs. 1,785 issue price. By the time the closing bell rang on day one, the stock had climbed further to settle at Rs. 1,818. A day later, as this is being written, it is trading closer to Rs. 1,806, a small pullback that is honestly more normal than anything to worry about. What has actually moved the conversation forward is Macquarie's note initiating coverage with an Outperform rating and a Rs. 1,965 target price, nicknaming NSE "The Dominator." Here is what that call is built on, where other brokerages disagree, and what it practically means if you hold the stock or are still deciding whether to buy it.

The Listing Nobody Was Sure Would Happen

For most of the last decade, an NSE IPO was the kind of thing traders joked about rather than expected. The exchange's public listing plans were frozen for years after the co-location scam investigations, and even once SEBI finally cleared the path, retail investors had reason to stay cautious, having heard "NSE IPO" promised and shelved more than once before. When SEBI actually gave its green light this time, the reaction on the ground was closer to disbelief than celebration, a shift we tracked in detail as the approval came through and what changed after it.

The issue itself turned out to be a study in mixed signals. Overall subscription closed at 5.69 times, a solid number on paper, but the grey market premium that had been running strong through the earlier days of the offer had crashed to just Rs. 58 by the final day of bidding, a sharp cooldown from where excitement had been building. Anyone who has followed how grey market premiums actually work and whether you can trust them knows they are a sentiment gauge, not a guarantee, and this issue was as good an example as any of that gap between hype and outcome.

Macquarie's "Dominator" Thesis

Macquarie's report leans on three pillars, entrenched network effects, industry-leading profitability, and a cash-generative business model that the brokerage argues underpins the entire Indian financialisation story. NSE currently commands somewhere close to 93 percent of cash market share and effectively all of stock and index futures volume, numbers that are difficult for any competitor to meaningfully dent in the near term.

On valuation, Macquarie pegs NSE at roughly 22 times estimated FY29 EV/EBITDA and around 29 to 30 times estimated FY29 earnings at the IPO price band, working out to about a 65 percent premium over international exchange peers, who trade closer to 18 times. The brokerage's argument is that this premium is earned, not inflated, pointing to roughly 60 percent higher growth and return ratios than those global peers. At its Rs. 1,965 target, the stock would work out to a PEG ratio of about 2.5 times, which Macquarie says lines up reasonably well with how growth exchanges are valued elsewhere.

It is worth noting Macquarie did not write a one-sided report. The brokerage flagged that the Closing Auction Session, the mechanism that has reshaped the last leg of every trading day since its rollout, is likely to weigh on cash equity, derivatives and margin trading volumes in the near term as the market keeps adjusting to it, a transition that has been closely tracked since its first month of data.

It's Not the Only Voice on the Street

Macquarie is bullish, but it isn't alone, and it also isn't the most bullish. Two other brokerages initiated coverage around the same time, and comparing all three side by side gives a fuller picture of where the disagreement actually sits.

Brokerage	Rating	Target Price	Upside from Rs. 1,818
Macquarie	Outperform	Rs. 1,965	~8%
PL Capital	Accumulate	Rs. 1,950	~7%
Emkay Global	Buy	Rs. 2,050	~13%

Zooming into the price action itself helps put these targets in context. NSE's first two days on the market have already told a small story of their own, a listing pop, a strong close, and then a modest breather.

The Margin Question Macquarie Didn't Duck

One number in the coverage deserves more attention than it has gotten. According to PL Capital's own numbers, NSE's EBITDA margin actually contracted to 71.3 percent in FY26, down from 77.8 percent in FY25, and the reason is not a demand problem, it comes down to settlement payments tied to pending legal cases that have now largely been resolved. With that overhang cleared, PL Capital expects margins to recover to around 76 percent by FY29, essentially back near where they used to sit.

This detail matters more than a passing footnote because it explains why the earnings multiple looks the way it does today. A business trading on FY29 estimates is, by definition, asking investors to look past a rough year and underwrite the recovery. That is a reasonable bet given NSE's market position, but it is still a bet, and worth understanding rather than glossing over before deciding how much of a position to hold or add.

Why This Listing Matters Beyond the Stock Itself

There is a bigger picture worth sitting with for a second. A listed NSE gives ordinary investors a direct way to own a slice of India's entire financialisation trend, more demat accounts, more SIPs, more F&O turnover, rather than betting on any single bank or brokerage benefiting from that growth. That is part of why brokerages across the board, bullish or cautious on specific numbers, largely agree on the underlying direction of the industry even when their price targets differ by more than Rs. 100.

BSE, the Quiet Second Half of the Same Report

Macquarie's coverage note did not stop at NSE. In the same breath, it initiated on BSE too, describing it as a credible "challenger" riding the same financialisation wave, with its pivot toward index options seen as a genuine source of share gains rather than a defensive move. The brokerage argues the market has not yet fully priced in BSE's potential to claw back volume in cash equities and F&O.

The two stocks are not perfect substitutes for each other, though. BSE has had its own rough patches with the Closing Auction Session, at one point sliding to a four-month low with the new session structure taking part of the blame. Investors comparing the two exchanges side by side would do well to read up on how their listing journeys and business models actually differ before assuming one is simply a cheaper version of the other.

What This Actually Means If You're a Retail Investor

If you got an allotment in the IPO, the honest starting point is that you are already sitting on a gain, Rs. 1,818 against a Rs. 1,785 cost price is real money, even if it is a smaller pop than the early grey market chatter had suggested. Whether to hold for Macquarie's Rs. 1,965 target or book something now is a personal call that depends on your own portfolio concentration and goals, not a headline target price from any single brokerage.

If you are considering buying in fresh at current levels, it helps to separate the story from the stock price for a moment. NSE's revenue is closely tied to F&O trading volumes, and regulatory changes like the newer margin rules for F&O trades directly affect how much retail activity actually flows through the exchange, which in turn affects NSE's own topline. That is a layer of risk that sits underneath any brokerage target price. Chasing a freshly listed stock purely on the strength of brokerage targets is also exactly the kind of behaviour behind why most traders in the market end up losing money, so keep position sizing sensible either way.

More broadly, a single stock reacting to a single set of analyst notes is rarely a good reason to override a long-term plan. The reasoning behind sticking to an active or passive approach that fits your own temperament, and the basic discipline of not letting one position or one bad call dictate your entire account, matters far more over ten years than whether NSE settles at Rs. 1,818 or Rs. 1,950 this particular week.

Frequently Asked Questions (FAQ)

1. What was NSE's IPO issue price and listing price?

NSE's IPO issue price was Rs. 1,785 per share, and the stock listed on BSE and MSEI at Rs. 1,800, closing its first trading day at Rs. 1,818.

2. What is Macquarie's price target for NSE?

Macquarie initiated coverage with an Outperform rating and a target price of Rs. 1,965, calling NSE "The Dominator" of India's exchange landscape.

3. Why did NSE's EBITDA margin drop in FY26?

The margin fell to 71.3 percent from 77.8 percent mainly due to settlement payments tied to pending legal cases, which have now largely been resolved.

4. Did Macquarie also cover BSE in the same report?

Yes, Macquarie described BSE as a credible "challenger" with its own re-rating potential, driven largely by its pivot toward index options.

5. Should retail investors buy NSE shares at current levels?

That depends on individual goals and portfolio concentration, not a single brokerage target, so it is worth weighing the valuation premium and near-term CAS-related risks before deciding.

6. Why does the Closing Auction Session matter for NSE's stock?

Macquarie flagged that the newer Closing Auction Session could weigh on cash equity, derivatives and margin trading volumes in the near term, which directly affects NSE's own revenue.